Coronary disease & ACSGuideline or statement
Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement
- Scientific statement
Recommendations
As issued by the authors
Routine aspirin for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in unselected populations is not supported by recent data; consideration should be reserved for those at highest ischemic risk
Balancing ischemic and bleeding risk requires individualized antiplatelet treatment
Original publication
Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement. J Am Coll Cardiol. Published 30 June 2026. doi:10.1016/j.jacc.2026.05.037
Summarised from the published abstract; every number is checked against it